SynthesisCardiovascular diabetology2026
Adolescent obesity and risk of serious chronic morbidity and mortality in young adulthood: a systematic review of cohorts from national registries.
Synthesis in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe rising prevalence of adolescent obesity necessitates a precise understanding of its corresponding risks for severe chronic morbidity and premature mortality during young adulthood and midlife.
methodsWe conducted a systematic review of nationwide longitudinal cohort studies, using validated national registries, aimed at assessing the short- and long-term risk of morbidity and mortality associated with adolescent overweight and obesity.
resultsWe included 38 studies in this systematic review. Adolescent overweight and obesity were associated with severe morbidity and disease related mortality, from young adulthood. Within < 4 years of follow-up and before the age of 25 years, severe adolescent obesity was associated with increased risk of serious morbidity (hazard ratio (HR) = 5.1 among men and HR = 7.3 among women), type 2 diabetes (HR = 27.0 among men, and HR = 45.3 among women), and obesity was associated with type 1 diabetes (HR = 2.0). Before the age of 30 years, adolescent severe obesity was associated with chronic kidney disease (CKD), obesity was associated with colorectal cancer (CRC) and with cardiovascular disease (CVD) mortality. Before the age of 40 years adolescent overweight and obesity were associated with ischemic stroke. Last, before the age of 50 years, adolescent severe obesity was associated with all-cause mortality, obesity was associated with diabetes mortality, and cancer.
conclusionsAdolescent obesity is strongly associated with an elevated hazard for severe disease morbidity and mortality beginning in young adulthood, with associations progressing with obesity severity and time. The findings of this study demonstrate the need for public health mitigation and preventive strategies, which may yield substantial short, and long-term health benefits in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.